Literature DB >> 31646903

Prediagnostic BMI and thyroid cancer incidence in the PLCO trial.

Omar Abdel-Rahman1,2.   

Abstract

Aim: To assess the correlation between prediagnostic BMI and thyroid cancer risk within the prostate, lung, colorectal and ovary (PLCO) trial.
Methods: PLCO trial participants without a history of thyroid cancer before study enrollment who have complete information about prediagnostic BMI were included. Multivariable Cox regression analyses were conducted to assess the impact of prediagnostic BMI on thyroid cancer risk.
Results: Higher BMI at the time of the study enrollment was associated with a higher thyroid cancer risk (hazard ratio: 1.046; p < 0.01). Furthermore, compared with a normal to normal prediagnostic BMI trajectory, both normal to overweight as well as normal to obese trajectories were associated with a higher thyroid cancer risk (p = 0.04 and p = 0.03, respectively).
Conclusion: Higher BMI at the time of study entry as well as an increasing prediagnostic BMI trajectory are associated with a higher thyroid cancer risk.

Entities:  

Keywords:  BMI; incidence; risk factor; thyroid cancer

Mesh:

Year:  2019        PMID: 31646903     DOI: 10.2217/fon-2019-0292

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  2 in total

1.  An Investigation on the Risk Factors of Thyroid Diseases in Community Population in Hainan.

Authors:  Tuanyu Fang; Leweihua Lin; Qianying Ou; Lu Lin; Huachuan Zhang; Kaining Chen; Huibiao Quan; Yangli He
Journal:  Int J Endocrinol       Date:  2022-07-09       Impact factor: 2.803

2.  A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer.

Authors:  Ping Lu; Yifei Ma; Jindan Kai; Jun Wang; Zhucheng Yin; Hongli Xu; Xinying Li; Xin Liang; Shaozhong Wei; Xinjun Liang
Journal:  Front Mol Biosci       Date:  2022-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.